Use of antioxidant and other complementary medicine by patients treated by antitumor chemotherapy: A prospective study;Prise d'antioxydants et d'autres thérapies complémentaires par les patients sous chimiothérapie antitumorale: Étude prospective

Bulletin du Cancer

Volumn 98, Issue 6, 2011, Pages 645-653

  Thomas Schoemann, Audrey ^a,b   Alexandre, Jérôme ^a   Mongaret, Céline ^a   Azibi, Sonia ^a   Dauphin, Alain ^a   Goldwasser, François ^a   Lemare, Francois ^b,c  

^a Service de Pharmacie ^*  (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Antioxidant; Antitumor chemotherapy; Complementary and alternative medicine; Interaction; Prevalence

Indexed keywords

ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ASCORBIC ACID; RETINOL; SELENIUM;

ACUPUNCTURE; ADULT; ALTERNATIVE MEDICINE; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; HOMEOPATHY; HUMAN; HYPNOSIS; IN VITRO STUDY; LEISURE; MAJOR CLINICAL STUDY; NEOPLASM; PHYSICIAN; PROSPECTIVE STUDY; TEA;

EID: 79959365220     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2011.1375     Document Type: Article

References (26)

1. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998 ; 280 : 1569-75.
2. Simon L, Prebay D, Beretz A, et al. Complementary and alternative medicines taken by cancer patients. Bull Cancer 2007 ; 94 : 483-8. (Pubitemid 46981012)
3. Smith P, Bullock JM, Booker BM, Haas CE, Berenson CS, Jusko WJ. The influence of St. John's wort on the pharmacokinetics and protein binding of imatinib mesylate. Pharmacotherapy 2004 ; 24 : 1508-14.
4. Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 2004 ; 7 : 97-110. (Pubitemid 38736063)
5. Alexandre J, Batteux F, Nicco C, et al. Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo. Int J Cancer 2006 ; 119 : 41-8.
6. Meyer F, Bairati I, Fortin A, et al. Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long-term effects on recurrence and mortality: a randomized trial among head and neck cancer patients. Int J Cancer 2008 ; 122 : 1679-83. (Pubitemid 351294980)
7. Golden EB, Lam PY, Kardosh A, et al. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood 2009 ; 113 : 5927-37.
8. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 1999 ; 340 : 1733-9. (Pubitemid 29252602)
9. Boon H, Westlake K, Stewart M, et al. Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics. Urology 2003 ; 62 : 849-53. (Pubitemid 37421230)
10. Ezzo JM, Richardson MA, Vickers A, et al. Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting. Cochrane Database Syst Rev 2006 ; 2 : CD002285.
11. Shen J, Wenger N, Glaspy J, et al. Electroacupuncture for control of myeloablative chemotherapy-induced emesis: a randomized controlled trial. JAMA 2000 ; 284 : 2755-61.
12. Kassab S, Cummings M, Berkovitz S, van Haselen R, Fisher P. Homeopathic medicines for adverse effects of cancer treatments. Cochrane Database Syst Rev 2009 ; 2 : CD004845.
13. Heaney ML, Gardner JR, Karasavvas N, et al. Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs. Cancer Res 2008 ; 68 : 8031-8.
14. Zou W, Yue P, Lin N, et al. Vitamin C inactivates the proteasome inhibitor PS-341 in human cancer cells. Clin Cancer Res 2006 ; 12 : 273-80. (Pubitemid 43166204)
15. Eberhardt MV, Lee CY, Liu RH. Antioxidant activity of fresh apples. Nature 2000 ; 405 : 903-4. (Pubitemid 30435037)
16. Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A, Blumberg JB. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst 2008 ; 100 : 773-83.
17. Greenlee H, Gammon MD, Abrahamson PE, et al. Prevalence and predictors of antioxidant supplement use during breast cancer treatment: the Long Island breast cancer study project. Cancer 2009 ; 115 : 3271-82.
18. Gupta D, Lis CG, Birdsall TC, Grutsch JF. The use of dietary supplements in a community hospital comprehensive cancer center: implications for conventional cancer care. Support Care Cancer 2005 ; 13 : 912-9. (Pubitemid 41502251)
19. Mohan IK, Khan M, Shobha JC, et al. Protection against cisplatin-induced nephrotoxicity by spirulina in rats. Cancer Chemother Pharmacol 2006 ; 58 : 802-8. (Pubitemid 44351261)
20. Lang M, Henson R, Braconi C, Patel T. Epigallocatechin-gallate modulates chemotherapy-induced apoptosis in human cholangiocarcinoma cells. Liver Int 2009 ; 29 : 670-7.
21. Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, Gyllenhaal C. Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials. Int J Cancer 2008 ; 123 : 1227-39.
22. Hickok JT, Roscoe JA, Morrow GR, Ryan JL. A phase II/III randomized, placebo-controlled, double-blind clinical trial of ginger (Zingiber officinale) for nausea caused by chemotherapy for cancer: a currently accruing URCC CCOP cancer control study. Support Cancer Ther 2007 ; 4 : 247-50. (Pubitemid 47606352)
23. Kim SM, Lee SY, Yuk DY, et al. Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel. Arch Pharm Res 2009 ; 32 : 755-65.
24. Dilhuydy JM. Patients' attraction to complementary and alternative medicine (CAM): a reality which physicians can neither ignore nor deny. Bull Cancer 2003 ; 90 : 623-8.
25. Sugiyama T, Sadzuka Y. Theanine, a specific glutamate derivative in green tea, reduces the adverse reactions of doxorubicin by changing the glutathione level. Cancer Lett 2004 ; 212 : 177-84. (Pubitemid 38997973)
26. Ramanathan B, Jan KY, Chen CH, Hour TC, Yu HJ, Pu YS. Resistance to paclitaxel is proportional to cellular total antioxidant capacity. Cancer Res 2005 ; 65 : 8455-60. (Pubitemid 41330613)